Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of PEN 498.25 billion. The enterprise value is 657.32 billion.

Market Cap	498.25B
Enterprise Value	657.32B

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 7, 2025

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	66.51%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 14.49 and the forward PE ratio is 8.75.

PE Ratio	14.49
Forward PE	8.75
PS Ratio	2.27
PB Ratio	1.53
P/TBV Ratio	n/a
P/FCF Ratio	13.73
P/OCF Ratio	10.89
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.62, with an EV/FCF ratio of 18.11.

EV / Earnings	19.12
EV / Sales	3.11
EV / EBITDA	7.62
EV / EBIT	10.98
EV / FCF	18.11

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.67.

Current Ratio	1.28
Quick Ratio	0.90
Debt / Equity	0.67
Debt / EBITDA	2.42
Debt / FCF	5.97
Interest Coverage	6.59

Financial Efficiency

Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 7.04%.

Return on Equity (ROE)	10.60%
Return on Assets (ROA)	5.19%
Return on Invested Capital (ROIC)	7.04%
Return on Capital Employed (ROCE)	10.33%
Revenue Per Employee	2.71M
Profits Per Employee	424,504
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.36

Taxes

Income Tax	-2.40B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.67%
50-Day Moving Average	25.39
200-Day Moving Average	24.65
Relative Strength Index (RSI)	71.45
Average Volume (20 Days)	779

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.92

Income Statement

In the last 12 months, Pfizer had revenue of PEN 219.64 billion and earned 34.38 billion in profits. Earnings per share was 6.04.

Revenue	219.64B
Gross Profit	164.31B
Operating Income	62.19B
Pretax Income	32.02B
Net Income	34.38B
EBITDA	85.56B
EBIT	62.19B
Earnings Per Share (EPS)	6.04

Full Income Statement

Balance Sheet

The company has 52.43 billion in cash and 216.68 billion in debt, giving a net cash position of -164.25 billion.

Cash & Cash Equivalents	52.43B
Total Debt	216.68B
Net Cash	-164.25B
Net Cash Per Share	n/a
Equity (Book Value)	325.68B
Book Value Per Share	57.10
Working Capital	36.13B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 45.75 billion and capital expenditures -9.45 billion, giving a free cash flow of 36.30 billion.

Operating Cash Flow	45.75B
Capital Expenditures	-9.45B
Free Cash Flow	36.30B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.81%, with operating and profit margins of 28.31% and 15.66%.

Gross Margin	74.81%
Operating Margin	28.31%
Pretax Margin	14.58%
Profit Margin	15.66%
EBITDA Margin	38.96%
EBIT Margin	28.31%
FCF Margin	16.53%

Dividends & Yields

This stock pays an annual dividend of 6.14, which amounts to a dividend yield of 23.44%.

Dividend Per Share	6.14
Dividend Yield	23.44%
Dividend Growth (YoY)	-2.29%
Years of Dividend Growth	1
Payout Ratio	98.75%
Buyback Yield	-0.18%
Shareholder Yield	23.26%
Earnings Yield	6.90%
FCF Yield	7.29%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7